biblio

Export 8 results:
Filters: Author is Sarkar, Dhiman and Keyword is tuberculosis  [Clear All Filters]
Journal Article
A. Khan, Sarkar, S., and Sarkar, D., Bactericidal activity of 2-nitroimidazole against the active replicating stage of mycobacterium bovis BCG and mycobacterium tuberculosis with intracellular efficacy in THP-1 macrophages, International Journal of Antimicrobial Agents, vol. 32, no. 1, pp. 40-45, 2008.
R. Singh, Nawale, L. U., Arkile, M. A., Shedbalkar, U. U., Wadhwani, S. A., Sarkar, D., and Chopade, B. Ananda, Chemical and biological metal nanoparticles as antimycobacterial agents: a comparative study, International Journal of Antimicrobial Agents, vol. 46, no. 2, pp. 183-188, 2015.
R. Balasaheb Aher and Sarkar, D., Pharmacophore modeling of pretomanid (PA-824) derivatives for antitubercular potency against replicating and non-replicating Mycobacterium tuberculosis, Journal of Biomolecular Structure & Dynamics, vol. 39, no. 3, pp. 889-900, 2021.
R. Singh, Nawale, L., Arkile, M. A., Wadhwani, S., Shedbalkar, U., Chopade, S., Sarkar, D., and Chopade, B. Ananda, Phytogenic silver, gold, and bimetallic nanoparticles as novel antitubercular agents, International Journal of Nanomedicine, vol. 11, p. 1889—1897, 2016.
A. Yeware, Akhtar, S., and Sarkar, D., Probes and techniques used in active and the hypoxia-based dormant state of an antitubercular drug screening assay, Medicine in Drug Discovery, vol. 13, p. 100115, 2022.
A. Mishra and Sarkar, D., Qualitative and quantitative proteomic analysis of vitamin C induced changes in mycobacterium smegmatis, Frontiers in Microbiology, vol. 6, p. Article Number: 451, 2015.
A. Khan and Sarkar, D., Simple whole cell based high throughput screening protocol using Mycobacterium bovis BCG for inhibitors against dormant and active tubercle bacilli, Journal of Microbiological Methods, vol. 73, no. 1, pp. 62-68, 2008.
T. S. Chitre, Asgaonkar, K. D., Miniyar, P. B., Dharme, A. B., Arkile, M. A., Yeware, A., Sarkar, D., Khedkar, V. M., and Jha, P. C., Synthesis and docking studies of pyrazine-thiazolidinone hybrid scaffold targeting dormant tuberculosis, Bioorganic & Medicinal Chemistry Letters, vol. 26, no. 9, pp. 2224-2228, 2016.